News

Oct 5

SCMR Invited to Present at Major Australian and International Scientific Meetings

Southern Cross Medical Radioisotopes will share its vision for Australian production of actinium-225 for targeted cancer therapies at three upcoming scientific meetings.

Mar 17 

SCMR Invited to Present at TAT-13, Rio de Janeiro

Southern Cross Medical Radioisotopes Director, Graeme Melville, has been invited to present SCMR’s research at the 13th International Symposium on Targeted Alpha Therapy in Rio de Janeiro, Brazil, in April 2026.

July 18

Advanced Radium & Actinium Separation Platform Developed

Southern Cross Medical Radioisotopes (SCMR) is developing a modern, high-efficiency liquid–liquid separation platform for processing legacy radium needles and recovering ultra-high purity radionuclides.

July 25

Radium Extraction from Australian Pitchblende

SCMR has successfully extended its advanced separation platform to the extraction of Ra-226 from Australian pitchblende (uranium ore).